Clinical

An educational session on Patient-Reported Outcomes in Hematology at the annual meeting of the American Society of Hematology, discussed the importance of embracing the patient perspective in healthcare delivery.

At the annual meeting of the American Society of Hematology, experts discussed quality measurement, public performance reporting, and pay-for-performance and it's impact on healthcare in the United States.

Thirteen hematologists on the American Society of Hematology(ASH)'s Choosing Wisely Task Force chose the top 5 of 380 recommendations listed by 70 other societies for presentation at ASH.

What we're reading, January 25, 2016: Cigna faces sanctions from CMS; a Massachusetts senator blocks the nomination of Robert Califf, MD, for FDA commissioner; and hospitals and health systems are mostly unprepared for precision medicine.

As Americans as asked to pay a greater portion of their healthcare expenditures, new insurance design models are being implemented, such as value-based insurance design, to combat issues like nonadherence.

Patient-reported symptoms in chronic obstructive pulmonary disease may contribute information that can be used to infer future exacerbations and related costs.

A look at the latest news in healthcare, including a study that identifies an increased risk of diabetes in cancer survivors, 2 FDA approvals, Senator Bernie Sanders released a plan for universal healthcare coverage in the US, and the economics of aging.

A program for homebound patients reduces spending and improves care in high-risk older Medicare beneficiaries.

Presenting patients with a one-page handout of information on additional interventions and data on the low value of a service did little to dissuade patients choosing to use a low-value service.

Carfilzomib has been approved by the FDA for use in combination with dexamethasone or lenalidomide, in patients with relapsed/refractory multiple myeloma who have previously received 1 to 3 lines of therapy.

An individualized comprehensive care package for acute exacerbation of chronic obstructive pulmonary disease patients reduces 90-day mortality.

Robert W. Dubois, MD, PhD, of National Pharmaceutical Council, will discuss care pathways, how they are created, their implementation in US healthcare, and more, on January 28, 1-2 pm ET, during a tweetchat.

At a joint session at the annual meeting of the American Society of Hematology, primary clinical reviewers from the FDA discussed the safety and efficacy issues of 3 very recently approved drugs for multiple myeloma, along with 2 clinicians who have extensive experience with these drugs in the real-world setting.

A session on the first day of the annual meeting of the American Society of Hematology, held December 5-8, 2015, in Orlando, Florida, clinicians discussed the promise and challenges of using newly approved hematology/oncology agents.

An estimated 15.7% of individuals 65 or older may have received nonrecommended screenings for prostate and breast cancer, according to a new study published in JAMA Oncology.

Palliative care initiated in the emergency department for patients with advanced cancer improves quality of life without shortening survival.

Patients with high mental health care costs incur nearly 30% more costs than the usual high-cost patients.

At the 57th annual meeting of the American Society of Hematology, oncologists discussed trial data evaluating combination therapies for multiple myeloma and lymphoma.

A retrospective analysis of data from the National Cancer Data Base has found that patients who had cancer surgery at 56 days after the end of combined chemoradiotherapy presented with the best overall survival and successful removal of their residual tumors.

A new law in California mandates hospitals recognize and involve family caregivers during hospital admissions and discharges in order to reduce the barriers for better care.

A study presented at the 2016 Cancer Survivorship Symposium hosted by the American Society of Clinical Oncology has identified significant uncertainty on who is responsible for the care of cancer survivors.

What we're reading, January 20, 2016: UnitedHealth losses on Obamacare health plans steepen; more "skin in the game" doesn't necessarily result in savvier shoppers; and despite recommendations few high school students are tested for HIV.

The results of a new JAMA study underscore the importance of advance care planning in improving the quality of care that patients receive at the end of life.

What we're reading, January 19, 2016: the Obama administration is looking to make it easier for patients to access their medical records; a clinical trial has left 1 brain dead and 4 hospitalized; and hospitals are experimenting with mobile technologies to track patient health at home.

Radiologists and breast cancer specialists disagree with the US Preventive Services Task Force recommendation of raising the age of screening mammography to 50 years.